Identification of dihalogenated proteins in rat intestinal mucosa injured by indomethacin

Journal of Clinical Biochemistry and Nutrition

Volumn 48, Issue 2, 2011, Pages 178-182

  Takagi, Tomohisa ^a   Naito, Yuji ^a   Okada, Hitomi ^a   Okayama, Tetsuya ^a   Mizushima, Katsura ^a   Yamada, Shinya ^a   Fukumoto, Kouhei ^a   Inoue, Ken ^a   Takaoka, Megumi ^a   Oya Ito, Tomoko ^a   Uchiyama, Kazuhiko ^a   Ishikawa, Takeshi ^a   Handa, Osamu ^a   Kokura, Satoshi ^a   Yagi, Nobuaki ^a   Ichikawa, Hiroshi ^a   Kato, Yoji ^b   Osawa, Toshihiko ^c   Yoshikawa, Toshikazu ^a  

^a KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

^b UNIVERSITY OF HYOGO   (Japan)

^c AICHI GAKUIN UNIVERSITY   (Japan)

Author keywords

Albumin; Dibromotyrosine; Enolase; Indomethacin

Indexed keywords

ALBUMIN; DIBROMOTYROSINE; ENOLASE; ENOLASE 1; INDOMETACIN; MYELOPEROXIDASE; TYROSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DISEASE SEVERITY; ENZYME ACTIVITY; INTESTINE INJURY; MALE; NEUTROPHIL CHEMOTAXIS; NONHUMAN; PROTEIN ANALYSIS; RAT; SMALL INTESTINE MUCOSA; TWO DIMENSIONAL GEL ELECTROPHORESIS;

RATTUS; RATTUS NORVEGICUS;

EID: 79952392131     PISSN: 09120009     EISSN: None     Source Type: Journal    
DOI: 10.3164/jcbn.10-93     Document Type: Article

References (39)

1. Allison MC, Howatson AG, Torrance CJ, Lee FD, Russell RI. Gastrointestinal damage associated with the use of nonsteroidal antiinflammatory drugs. N Engl J Med 1992; 327: 749-754.
2. Fries JF, Williams CA, Bloch DA, Michel BA. Nonsteroidal anti-inflammatory drug-associated gastropathy: incidence and risk factor models. Am J Med 1991; 91: 213-222.
3. Naito Y, Iinuma S, Yagi N, and et al. Prevention of indomethacin-induced gastric mucosal injury in helicobacter pylori-negative healthy volunteers: a comparison study rebamipide vs famotidine. J Clin Biochem Nutr 2008; 43: 34-40.
4. Park SH, Cho CS, Lee OY, and et al. Comparison of prevention of NSAID-induced gastrointestinal complications by rebamipide and misoprostol: a randomized, multicenter, controlled trial-STORM STUDY. J Clin Biochem Nutr 2007; 40: 148-155.
5. Matsumoto T, Kudo T, Esaki M, and et al. Prevalence of non-steroidal anti-inflammatory drug-induced enteropathy determined by double-balloon endoscopy: a Japanese multicenter study. Scand J Gastroenterol 2008; 43: 490-496. (Pubitemid 351450993)
6. Higuchi K, Umegaki E, Watanabe T, and et al. Present status and strategy of NSAIDs-induced small bowel injury. J Gastroenterol 2009; 44: 879-888.
7. Harusato A, Naito Y, Takagi T, and et al. Inhibition of Bach1 ameliorates indomethacin-induced intestinal injury in mice. J Physiol Pharmacol 2009; 60 Suppl 7: 149-154.
8. Higuchi K, Yoda Y, Amagase K, and et al. Prevention of NSAID-induced small intestinal mucosal injury: prophylactic potential of lansoprazole. J Clin Biochem Nutr 2009; 45: 125-130.
9. Weissenborn U, Maedge S, Buettner D, Sewing KF. Indometacin-induced gastrointestinal lesions in relation to tissue concentration, food intake and bacterial invasion in the rat. Pharmacology 1985; 30: 32-39. (Pubitemid 15177152)
10. Whittle BJ. Temporal relationship between cyclooxygenase inhibition, as measured by prostacyclin biosynthesis, and the gastrointestinal damage induced by indomethacin in the rat. Gastroenterology 1981; 80: 94-98.
11. Whittle BJ, László F, Evans SM, Moncada S. Induction of nitric oxide synthase and microvascular injury in the rat jejunum provoked by indomethacin. Br J Pharmacol 1995; 116: 2286-2290.
12. Stadnyk AW, Dollard C, Issekutz TB, Issekutz AC. Neutrophil migration into indomethacin induced rat small intestinal injury is CD11a/CD18 and CD11b/ CD18 co-dependent. Gut 2002; 50: 629-635. (Pubitemid 34407488)
13. Kuroda M, Yoshida N, Ichikawa H, and et al. Lansoprazole, a proton pump inhibitor, reduces the severity of indomethacin-induced rat enteritis. Int J Mol Med 2006; 17: 89-93.
14. Okuda T, Yoshida N, Takagi T, and et al. CV-11974, angiotensin II type I receptor antagonist, reduces the severity of indomethacin-induced rat enteritis. Dig Dis Sci 2008; 53: 657-663. (Pubitemid 351320497)
15. Beck PL, Xavier R, Lu N, and et al. Mechanisms of NSAID-induced gastrointestinal injury defined using mutant mice. Gastroenterology 2000; 119: 699-705.
16. Watanabe T, Higuchi K, Kobata A, and et al. Non-steroidal anti-inflammatory drug-induced small intestinal damage is Toll-like receptor 4 dependent. Gut 2008; 57: 181-187. (Pubitemid 351158044)
17. Domigan NM, Charlton TS, Duncan MW, Winterbourn CC, Kettle AJ. Chlorination of tyrosyl residues in peptides by myeloperoxidase and human neutrophils. J Biol Chem 1995; 270: 16542-16548.
18. Hazen SL, Hsu FF, Mueller DM, Crowley JR, Heinecke JW. Human neutrophils employ chlorine gas as an oxidant during phagocytosis. J Clin Invest 1996; 98: 1283-1289. (Pubitemid 26322052)
19. Albert CJ, Thukkani AK, Heuertz RM, Slungaard A, Hazen SL, Ford DA. Eosinophil peroxidase-derived reactive brominating species target the vinyl ether bond of plasmalogens generating a novel chemoattractant, alphabromo fatty aldehyde. J Biol Chem 2003; 278: 8942-8950. (Pubitemid 36800371)
20. Thukkani AK, Albert CJ, Wildsmith KR, and et al. Myeloperoxidase-derived reactive chlorinating species from human monocytes target plasmalogens in low density lipoprotein. J Biol Chem 2003; 278: 36365-36372. (Pubitemid 37139964)
21. Henderson JP, Byun J, Heinecke JW. Molecular chlorine generated by the myeloperoxidase-hydrogen peroxide-chloride system of phagocytes produces 5-chlorocytosine in bacterial RNA. J Biol Chem 1999; 274: 33440-33448. (Pubitemid 129511650)
22. Shen Z, Mitra SN, Wu W, and et al. Eosinophil peroxidase catalyzes bromination of free nucleosides and double-stranded DNA. Biochemistry 2001; 40: 2041-2051. (Pubitemid 32165673)
23. Masuda M, Suzuki T, Friesen MD, and et al. Chlorination of guanosine and other nucleosides by hypochlorous acid and myeloperoxidase of activated human neutrophils. Catalysis by nicotine and trimethylamine. J Biol Chem 2001; 276: 40486-40496.
24. Kato Y, Kawai Y, Morinaga H, and et al. Immunogenicity of a brominated protein and successive establishment of a monoclonal antibody to dihalogenated tyrosine. Free Radic Biol Med 2005; 38: 24-31. (Pubitemid 39626905)
25. Wu W, Chen Y, d'Avignon A, Hazen SL. 3-Bromotyrosine and 3,5-dibromotyrosine are major products of protein oxidation by eosinophil peroxidase: potential markers for eosinophil-dependent tissue injury in vivo. Biochemistry 1999; 38: 3538-3548.
26. Grisham MB, Hernandez LA, Granger DN. Xanthine oxidase and neutrophil infiltration in intestinal ischemia. Am J Physiol 1986; 251: G567-G574.
27. Kouoh F, Gressier B, Luyckx M, and et al. Antioxidant properties of albumin: effect on oxidative metabolism of human neutrophil granulocytes. Farmaco 1999; 54: 695-699. (Pubitemid 29494924)
28. Guedes S, Vitorino R, Domingues R, Amado F, Domingues P. Oxidation of bovine serum albumin: identification of oxidation products and structural modifications. Rapid Commun Mass Spectrom 2009; 23: 2307-2315.
29. Gentile F, Pizzimenti S, Arcaro A, and et al. Exposure of HL-60 human leukaemic cells to 4-hydroxynonenal promotes the formation of adduct(s) with alpha-enolase devoid of plasminogen binding activity. Biochem J 2009; 422: 285-294.
30. Kumagai A, Nakayashiki N, Aoki Y. Analysis of age-related carbonylation of human vitreous humor proteins as a tool for forensic diagnosis. Leg Med (Tokyo) 2007; 175-180. (Pubitemid 46824121)
31. Lii CK, Lin AH, Lee SL, Chen HW, Wang TS. Oxidative modifications of proteins by sodium arsenite in human umbilical vein endothelial cells. Environ Toxicol 2010 [Epub ahead of print].
32. Reed TT, Pierce WM, Markesbery WR, Butterfield DA. Proteomic identification of HNE-bound proteins in early Alzheimer disease: Insights into the role of lipid peroxidation in the progression of AD. Brain Res 2009; 1274: 66-76.
33. Sultana R, Poon HF, Cai J, and et al. Identification of nitrated proteins in Alzheimer's disease brain using a redox proteomics approach. Neurobiol Dis 2006; 22: 76-87.
34. Pancholi V. Multifunctional alpha-enolase: its role in diseases. Cell Mol Life Sci 2001; 58: 902-920. (Pubitemid 32652817)
35. Miles LA, Dahlberg CM, Plescia J, Felez J, Kato K, Plow EF. Role of cell-surface lysines in plasminogen binding to cells: identification of alphaenolase as a candidate plasminogen receptor. Biochemistry 1991; 30: 1682-1691.
36. Jankowska R, Witkowska D, Porebska I, Kuropatwa M, Kurowska E, Gorczyca WA. Serum antibodies to retinal antigens in lung cancer and sarcoidosis. Pathobiology 2004; 71: 323-328. (Pubitemid 40082313)
37. Li C, Xiao Z, Chen Z, and et al. Proteome analysis of human lung squamous carcinoma. Proteomics 2006; 6: 547-558. (Pubitemid 43208034)
38. Chang GC, Liu KJ, Hsieh CL, and et al. Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes. Clin Cancer Res 2006; 12: 5746-5754.
39. Wygrecka M, Marsh LM, Morty RE, and et al. Enolase-1 promotes plasminogen-mediated recruitment of monocytes to the acutely inflamed lung. Blood 2009; 113: 5588-5598.